1) Platinum SPARK:  Protocol No. P276-00/64/11 “A Multicenter, Phase II/III Study to Assess Radiation Induced Mucositis in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Administered Cisplatin and Radiation with or without P276-00 .

2) Protocol :-RC/0111/009 :   A Multicenter ,randomized, open label, single dose, two treatment, three period, three sequence, partial, replicate, cross- over ,pivotal bioequivalence, study of test capecitabine 500 mg tablet manufactured by Reliance life Sciences .Pvt. Ltd., India with Xeloda (Capecitabine 500 mg ) manufactured by Roche Pharma, AG , Germany in adult, human cancer patients under fed condition.

3) BI LUX- Head & Neck 2:  A randomized, double blind, placebo- controlled, phase III study to evaluate the efficacy and safety of afatinib (BIBW 2992) as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III, IVa or IVb loco-regionally advanced head and neck squamous cell carcinoma.